Glycogen
synthase kinase 3 beta (GSK-3β) is an attractive target for the
treatment of psychiatric disorders and neurodegenerative diseases. Many GSK-3β
inhibitors have been developed for the treatment of different central nervous
system disorders. But, for an effective...
